AVDL: Avadel Pharmaceuticals plc Ordinary Share Company Profile & Statistics

About

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.

Info & Links

CEO

Gregory J. Divis

Headquarters

10 EARLSFORT TERRACE
DUBLIN, L2 D02 T380, IRELAND

Auditor

Deloitte and Touche LLP

Share holders

Employees

154

Avadel Pharmaceuticals plc Ordinary Share Statistics

Valuation Measures

Market Capitalization²

810.88M

Enterprise Value

782.30M

Enterprise Value/EBITDA(ttm)

-12.62

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.87

Price to Book(mrq)

10.85

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

92.95%

Operating Margin(ttm)

-52.53%

Profit Margin(ttm)

-71.78%

Return on Equity(ttm)

-93.34%

Return on Invested Capital(ttm)

-90.87%

Return on Assets(ttm)

-44.77%

Income Statement

Revenue(ttm)

138.16M

Revenue Per Share(ttm)

1.43

Gross Profit(ttm)

127.00M

EBITDA(ttm)³

-62.01M

Net Income Available to Common(ttm)

-72.58M

Diluted EPS(ttm)

-0.79

Share Statistics

Beta (5Y Monthly)

1.28

52-Week Change

-34.64%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

96.36M

Dividend Yield

0.00%

Float⁴

91.74M

% Held by Insiders

4.80%

% Held by Institutions

69.19%

Balance Sheet

Total Cash(mrq)

65.81M

Total Cash Per Share(mrq)

0.68

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.97%

Quick Ratio(mrq)

2.60%

Book Value Per Share(mrq)

0.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.57

Free Cash Flow(ytd)

-54.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AVDL

Avadel Pharmaceuticals plc Ordinary Share

Avadel Pharmaceuticals plc Ordinary Share Profile